Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival-Reference-Cited by-同舟云学术

Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival

Published:2021-09 Issue:3 Volume:217 Page:730-740
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Panda Ananya¹,Garg Ishan¹,Truty Mark J.²,Kline Timothy L.¹,Johnson Matthew P.³,Ehman Eric C.¹,Suman Garima¹,Anaam Deema A.¹,Kemp Bradley J.¹,Johnson Geoffrey B.¹,Halfdanarson Thorvardur R.⁴,Venkatesh Sudhakar K.¹,Fidler Jeff L.¹,Goenka Ajit H.¹

Affiliation:

1. Department of Radiology, Mayo Clinic, 200 First St SW, Charlton 1, Rochester, MN 55905

2. Department of Surgery, Mayo Clinic, Rochester, MN

3. Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

4. Department of Medical Oncology, Mayo Clinic, Rochester, MN

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.20.24567

Reference39 articles.